Modifi Bio

A bold and innovative biotech, Modifi Bio is developing a novel oncology therapeutics platform that exploits DNA defects in a wide range of cancer cells, and which aims to disrupt conventional oncology drug development. This entirely new approach to fighting cancer is based on our ability to modify tumor DNA in a manner that is irreparable to cancer cells, without negatively impacting healthy cells. Specifically, we have created a new class of small molecules which directly target DNA, thereby avoiding the need to engage protein targets directly, which exploit tumor-associated DNA repair defects. Leveraging emerging discoveries from the co-founders laboratories recently published in Science, our strategy has already been validated in a wide range of tumor types, both in vitro and in vivo. The founding team includes world-renowned scientists, clinicians, and experienced biotech entrepreneurs, united by a shared vision to improve the lives of cancer patients. The core technology wa...